中国男科学杂志
中國男科學雜誌
중국남과학잡지
CHINESE JOURNAL OF ANDROLOGY
2013年
10期
33-38
,共6页
肖二龙%鲁骋洲%丁慧%李永前%王志平
肖二龍%魯騁洲%丁慧%李永前%王誌平
초이룡%로빙주%정혜%리영전%왕지평
磷酸二酯酶抑制剂%早泄%系统评价
燐痠二酯酶抑製劑%早洩%繫統評價
린산이지매억제제%조설%계통평개
phosphodiesterase inhibitors%premature Ejaculation%systematic review
目的:系统评价5型磷酸二酯酶抑制剂对治疗早泄患者及性功能正常人的临床疗效和安全性。方法检索国内外有关比较5型磷酸二酯酶抑制剂和安慰剂用于治疗早泄患者及性功能正常人的随机对照试验和随机交叉实验,由两名评价员独立按Cochrane系统评价方法对文献进行质量评价和提取资料后,采用RevMan 5.2统计软件进行系统评价,对于不能合并的效应量采用描述性研究。结果共纳入10个随机对照试验和随机交叉实验,512例患者。结果显示,5型磷酸二酯酶抑制剂可以提高早泄患者的射精潜伏期(IELT),缩短患者的射精后勃起潜伏期(PERT),提高性生活满意率。对于性功能正常人使用5型磷酸二酯酶抑制剂类药物可以缩短PERT,但能否提高IELT还存在一定争议。5型磷酸二酯酶抑制剂组副作用发生率较安慰剂组高。结论对于早泄患者可以尝试使用5型磷酸二酯酶抑制剂来治疗,对于性功能正常人要慎用5型磷酸二酯酶抑制剂。由于文献纳入的较少,需要更多大样本的随机对照试验进一步证实。
目的:繫統評價5型燐痠二酯酶抑製劑對治療早洩患者及性功能正常人的臨床療效和安全性。方法檢索國內外有關比較5型燐痠二酯酶抑製劑和安慰劑用于治療早洩患者及性功能正常人的隨機對照試驗和隨機交扠實驗,由兩名評價員獨立按Cochrane繫統評價方法對文獻進行質量評價和提取資料後,採用RevMan 5.2統計軟件進行繫統評價,對于不能閤併的效應量採用描述性研究。結果共納入10箇隨機對照試驗和隨機交扠實驗,512例患者。結果顯示,5型燐痠二酯酶抑製劑可以提高早洩患者的射精潛伏期(IELT),縮短患者的射精後勃起潛伏期(PERT),提高性生活滿意率。對于性功能正常人使用5型燐痠二酯酶抑製劑類藥物可以縮短PERT,但能否提高IELT還存在一定爭議。5型燐痠二酯酶抑製劑組副作用髮生率較安慰劑組高。結論對于早洩患者可以嘗試使用5型燐痠二酯酶抑製劑來治療,對于性功能正常人要慎用5型燐痠二酯酶抑製劑。由于文獻納入的較少,需要更多大樣本的隨機對照試驗進一步證實。
목적:계통평개5형린산이지매억제제대치료조설환자급성공능정상인적림상료효화안전성。방법검색국내외유관비교5형린산이지매억제제화안위제용우치료조설환자급성공능정상인적수궤대조시험화수궤교차실험,유량명평개원독립안Cochrane계통평개방법대문헌진행질량평개화제취자료후,채용RevMan 5.2통계연건진행계통평개,대우불능합병적효응량채용묘술성연구。결과공납입10개수궤대조시험화수궤교차실험,512례환자。결과현시,5형린산이지매억제제가이제고조설환자적사정잠복기(IELT),축단환자적사정후발기잠복기(PERT),제고성생활만의솔。대우성공능정상인사용5형린산이지매억제제류약물가이축단PERT,단능부제고IELT환존재일정쟁의。5형린산이지매억제제조부작용발생솔교안위제조고。결론대우조설환자가이상시사용5형린산이지매억제제래치료,대우성공능정상인요신용5형린산이지매억제제。유우문헌납입적교소,수요경다대양본적수궤대조시험진일보증실。
Objective To compare the efficacy and safety of phosphodiesterase type 5 inhibitors (PDE5-Is) in the treatment of premature ejaculation and normal sexual function through a systematic review.Methods All randomized controlled trials and randomized crossover trials of PDE5-Is and placebo in the treatment of premature ejaculation and normal sexual function were collected. The quality of included trials was assessed. Relevant data were selected according to the standard of Cochrane systematic review by two reviewers. Statistical software Revman 5.2 was used for systematic review.Results Ten randomized controlled trials and randomized crossover trials with 512 cases were included. For patients with the premature ejaculation, the PDE5-Is can prolong the intravaginal ejaculation latency time, decrease the post-ejaculatory refractory time and improve thesexual satisfaction rate. For people with normal sexual function, PDE5-Is caused a reduction of the post-ejaculatory refractory time. However, there was controversy about its effcet on the intravaginal ejaculation latency time. PDE5-Is have more adverse reaction.Conculsion For patients with the premature ejaculation, PDE5-Is was recommended to use in clinic, but for the normal sexual function people, PDE5-Is should be used cautionly. Because of the limited references,, more high quality randomized controlled trials with large samples are required to get further confirmation.